1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Eye Disorders Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cataract Surgery Devices 1.2.3 Glaucoma Surgery Devices 1.2.4 Vitreoretinal Surgery Devices 1.2.5 Refractive Surgery Devices 1.3 Market by Application 1.3.1 Global Eye Disorders Treatments Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Eye Disorders Treatments Market Perspective (2016-2027) 2.2 Eye Disorders Treatments Growth Trends by Regions 2.2.1 Eye Disorders Treatments Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Eye Disorders Treatments Historic Market Share by Regions (2016-2021) 2.2.3 Eye Disorders Treatments Forecasted Market Size by Regions (2022-2027) 2.3 Eye Disorders Treatments Industry Dynamic 2.3.1 Eye Disorders Treatments Market Trends 2.3.2 Eye Disorders Treatments Market Drivers 2.3.3 Eye Disorders Treatments Market Challenges 2.3.4 Eye Disorders Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Eye Disorders Treatments Players by Revenue 3.1.1 Global Top Eye Disorders Treatments Players by Revenue (2016-2021) 3.1.2 Global Eye Disorders Treatments Revenue Market Share by Players (2016-2021) 3.2 Global Eye Disorders Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Eye Disorders Treatments Revenue 3.4 Global Eye Disorders Treatments Market Concentration Ratio 3.4.1 Global Eye Disorders Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Eye Disorders Treatments Revenue in 2020 3.5 Eye Disorders Treatments Key Players Head office and Area Served 3.6 Key Players Eye Disorders Treatments Product Solution and Service 3.7 Date of Enter into Eye Disorders Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Eye Disorders Treatments Breakdown Data by Type 4.1 Global Eye Disorders Treatments Historic Market Size by Type (2016-2021) 4.2 Global Eye Disorders Treatments Forecasted Market Size by Type (2022-2027) 5 Eye Disorders Treatments Breakdown Data by Application 5.1 Global Eye Disorders Treatments Historic Market Size by Application (2016-2021) 5.2 Global Eye Disorders Treatments Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Eye Disorders Treatments Market Size (2016-2027) 6.2 North America Eye Disorders Treatments Market Size by Type 6.2.1 North America Eye Disorders Treatments Market Size by Type (2016-2021) 6.2.2 North America Eye Disorders Treatments Market Size by Type (2022-2027) 6.2.3 North America Eye Disorders Treatments Market Size by Type (2016-2027) 6.3 North America Eye Disorders Treatments Market Size by Application 6.3.1 North America Eye Disorders Treatments Market Size by Application (2016-2021) 6.3.2 North America Eye Disorders Treatments Market Size by Application (2022-2027) 6.3.3 North America Eye Disorders Treatments Market Size by Application (2016-2027) 6.4 North America Eye Disorders Treatments Market Size by Country 6.4.1 North America Eye Disorders Treatments Market Size by Country (2016-2021) 6.4.2 North America Eye Disorders Treatments Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Eye Disorders Treatments Market Size (2016-2027) 7.2 Europe Eye Disorders Treatments Market Size by Type 7.2.1 Europe Eye Disorders Treatments Market Size by Type (2016-2021) 7.2.2 Europe Eye Disorders Treatments Market Size by Type (2022-2027) 7.2.3 Europe Eye Disorders Treatments Market Size by Type (2016-2027) 7.3 Europe Eye Disorders Treatments Market Size by Application 7.3.1 Europe Eye Disorders Treatments Market Size by Application (2016-2021) 7.3.2 Europe Eye Disorders Treatments Market Size by Application (2022-2027) 7.3.3 Europe Eye Disorders Treatments Market Size by Application (2016-2027) 7.4 Europe Eye Disorders Treatments Market Size by Country 7.4.1 Europe Eye Disorders Treatments Market Size by Country (2016-2021) 7.4.2 Europe Eye Disorders Treatments Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Eye Disorders Treatments Market Size (2016-2027) 8.2 Asia-Pacific Eye Disorders Treatments Market Size by Type 8.2.1 Asia-Pacific Eye Disorders Treatments Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Eye Disorders Treatments Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Eye Disorders Treatments Market Size by Type (2016-2027) 8.3 Asia-Pacific Eye Disorders Treatments Market Size by Application 8.3.1 Asia-Pacific Eye Disorders Treatments Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Eye Disorders Treatments Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Eye Disorders Treatments Market Size by Application (2016-2027) 8.4 Asia-Pacific Eye Disorders Treatments Market Size by Region 8.4.1 Asia-Pacific Eye Disorders Treatments Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Eye Disorders Treatments Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Eye Disorders Treatments Market Size (2016-2027) 9.2 Latin America Eye Disorders Treatments Market Size by Type 9.2.1 Latin America Eye Disorders Treatments Market Size by Type (2016-2021) 9.2.2 Latin America Eye Disorders Treatments Market Size by Type (2022-2027) 9.2.3 Latin America Eye Disorders Treatments Market Size by Type (2016-2027) 9.3 Latin America Eye Disorders Treatments Market Size by Application 9.3.1 Latin America Eye Disorders Treatments Market Size by Application (2016-2021) 9.3.2 Latin America Eye Disorders Treatments Market Size by Application (2022-2027) 9.3.3 Latin America Eye Disorders Treatments Market Size by Application (2016-2027) 9.4 Latin America Eye Disorders Treatments Market Size by Country 9.4.1 Latin America Eye Disorders Treatments Market Size by Country (2016-2021) 9.4.2 Latin America Eye Disorders Treatments Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Eye Disorders Treatments Market Size (2016-2027) 10.2 Middle East & Africa Eye Disorders Treatments Market Size by Type 10.2.1 Middle East & Africa Eye Disorders Treatments Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Eye Disorders Treatments Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Eye Disorders Treatments Market Size by Type (2016-2027) 10.3 Middle East & Africa Eye Disorders Treatments Market Size by Application 10.3.1 Middle East & Africa Eye Disorders Treatments Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Eye Disorders Treatments Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Eye Disorders Treatments Market Size by Application (2016-2027) 10.4 Middle East & Africa Eye Disorders Treatments Market Size by Country 10.4.1 Middle East & Africa Eye Disorders Treatments Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Eye Disorders Treatments Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Details 11.1.2 Johnson & Johnson Business Overview 11.1.3 Johnson & Johnson Eye Disorders Treatments Introduction 11.1.4 Johnson & Johnson Revenue in Eye Disorders Treatments Business (2016-2021) 11.1.5 Johnson & Johnson Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Eye Disorders Treatments Introduction 11.2.4 Novartis Revenue in Eye Disorders Treatments Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Alimera Sciences 11.3.1 Alimera Sciences Company Details 11.3.2 Alimera Sciences Business Overview 11.3.3 Alimera Sciences Eye Disorders Treatments Introduction 11.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2016-2021) 11.3.5 Alimera Sciences Recent Development 11.4 Teva Pharmaceutical 11.4.1 Teva Pharmaceutical Company Details 11.4.2 Teva Pharmaceutical Business Overview 11.4.3 Teva Pharmaceutical Eye Disorders Treatments Introduction 11.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2016-2021) 11.4.5 Teva Pharmaceutical Recent Development 11.5 Eyetech Pharmaceuticals 11.5.1 Eyetech Pharmaceuticals Company Details 11.5.2 Eyetech Pharmaceuticals Business Overview 11.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Introduction 11.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2016-2021) 11.5.5 Eyetech Pharmaceuticals Recent Development 11.6 Refocus Group 11.6.1 Refocus Group Company Details 11.6.2 Refocus Group Business Overview 11.6.3 Refocus Group Eye Disorders Treatments Introduction 11.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2016-2021) 11.6.5 Refocus Group Recent Development 11.7 VisionCare Ophthalmic Technologies 11.7.1 VisionCare Ophthalmic Technologies Company Details 11.7.2 VisionCare Ophthalmic Technologies Business Overview 11.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Introduction 11.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2016-2021) 11.7.5 VisionCare Ophthalmic Technologies Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Eye Disorders Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cataract Surgery Devices Table 3. Key Players of Glaucoma Surgery Devices Table 4. Key Players of Vitreoretinal Surgery Devices Table 5. Key Players of Refractive Surgery Devices Table 6. Global Eye Disorders Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Eye Disorders Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Eye Disorders Treatments Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Eye Disorders Treatments Market Share by Regions (2016-2021) Table 10. Global Eye Disorders Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Eye Disorders Treatments Market Share by Regions (2022-2027) Table 12. Eye Disorders Treatments Market Trends Table 13. Eye Disorders Treatments Market Drivers Table 14. Eye Disorders Treatments Market Challenges Table 15. Eye Disorders Treatments Market Restraints Table 16. Global Eye Disorders Treatments Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Eye Disorders Treatments Market Share by Players (2016-2021) Table 18. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2020) Table 19. Ranking of Global Top Eye Disorders Treatments Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Eye Disorders Treatments Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Eye Disorders Treatments Product Solution and Service Table 23. Date of Enter into Eye Disorders Treatments Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 26. Global Eye Disorders Treatments Revenue Market Share by Type (2016-2021) Table 27. Global Eye Disorders Treatments Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Eye Disorders Treatments Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Eye Disorders Treatments Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Eye Disorders Treatments Revenue Market Share by Application (2016-2021) Table 31. Global Eye Disorders Treatments Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Eye Disorders Treatments Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 34. North America Eye Disorders Treatments Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Eye Disorders Treatments Market Size by Application (2016-2021) (US$ Million) Table 36. North America Eye Disorders Treatments Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Eye Disorders Treatments Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Eye Disorders Treatments Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Eye Disorders Treatments Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Eye Disorders Treatments Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Eye Disorders Treatments Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Eye Disorders Treatments Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Eye Disorders Treatments Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Eye Disorders Treatments Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Eye Disorders Treatments Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Eye Disorders Treatments Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Eye Disorders Treatments Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Eye Disorders Treatments Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Eye Disorders Treatments Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Eye Disorders Treatments Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Eye Disorders Treatments Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Eye Disorders Treatments Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Eye Disorders Treatments Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Eye Disorders Treatments Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Eye Disorders Treatments Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Eye Disorders Treatments Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Eye Disorders Treatments Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Eye Disorders Treatments Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Eye Disorders Treatments Market Size by Country (2022-2027) & (US$ Million) Table 63. Johnson & Johnson Company Details Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Eye Disorders Treatments Product Table 66. Johnson & Johnson Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 67. Johnson & Johnson Recent Development Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Eye Disorders Treatments Product Table 71. Novartis Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 72. Novartis Recent Development Table 73. Alimera Sciences Company Details Table 74. Alimera Sciences Business Overview Table 75. Alimera Sciences Eye Disorders Treatments Product Table 76. Alimera Sciences Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 77. Alimera Sciences Recent Development Table 78. Teva Pharmaceutical Company Details Table 79. Teva Pharmaceutical Business Overview Table 80. Teva Pharmaceutical Eye Disorders Treatments Product Table 81. Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 82. Teva Pharmaceutical Recent Development Table 83. Eyetech Pharmaceuticals Company Details Table 84. Eyetech Pharmaceuticals Business Overview Table 85. Eyetech Pharmaceuticals Eye Disorders Treatments Product Table 86. Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 87. Eyetech Pharmaceuticals Recent Development Table 88. Refocus Group Company Details Table 89. Refocus Group Business Overview Table 90. Refocus Group Eye Disorders Treatments Product Table 91. Refocus Group Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 92. Refocus Group Recent Development Table 93. VisionCare Ophthalmic Technologies Company Details Table 94. VisionCare Ophthalmic Technologies Business Overview Table 95. VisionCare Ophthalmic Technologies Eye Disorders Treatments Product Table 96. VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2016-2021) & (US$ Million) Table 97. VisionCare Ophthalmic Technologies Recent Development Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Eye Disorders Treatments Market Share by Type: 2020 VS 2027 Figure 2. Cataract Surgery Devices Features Figure 3. Glaucoma Surgery Devices Features Figure 4. Vitreoretinal Surgery Devices Features Figure 5. Refractive Surgery Devices Features Figure 6. Global Eye Disorders Treatments Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Others Case Studies Figure 10. Eye Disorders Treatments Report Years Considered Figure 11. Global Eye Disorders Treatments Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Eye Disorders Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Eye Disorders Treatments Market Share by Regions: 2020 VS 2027 Figure 14. Global Eye Disorders Treatments Market Share by Regions (2022-2027) Figure 15. Global Eye Disorders Treatments Market Share by Players in 2020 Figure 16. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Eye Disorders Treatments Revenue in 2020 Figure 18. Global Eye Disorders Treatments Revenue Market Share by Type (2016-2021) Figure 19. Global Eye Disorders Treatments Revenue Market Share by Type (2022-2027) Figure 20. North America Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Eye Disorders Treatments Market Share by Type (2016-2027) Figure 22. North America Eye Disorders Treatments Market Share by Application (2016-2027) Figure 23. North America Eye Disorders Treatments Market Share by Country (2016-2027) Figure 24. United States Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Eye Disorders Treatments Market Share by Type (2016-2027) Figure 28. Europe Eye Disorders Treatments Market Share by Application (2016-2027) Figure 29. Europe Eye Disorders Treatments Market Share by Country (2016-2027) Figure 30. Germany Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Eye Disorders Treatments Market Share by Type (2016-2027) Figure 38. Asia-Pacific Eye Disorders Treatments Market Share by Application (2016-2027) Figure 39. Asia-Pacific Eye Disorders Treatments Market Share by Region (2016-2027) Figure 40. China Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Eye Disorders Treatments Market Share by Type (2016-2027) Figure 48. Latin America Eye Disorders Treatments Market Share by Application (2016-2027) Figure 49. Latin America Eye Disorders Treatments Market Share by Country (2016-2027) Figure 50. Mexico Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Eye Disorders Treatments Market Share by Type (2016-2027) Figure 54. Middle East & Africa Eye Disorders Treatments Market Share by Application (2016-2027) Figure 55. Middle East & Africa Eye Disorders Treatments Market Share by Country (2016-2027) Figure 56. Turkey Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Eye Disorders Treatments Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Johnson & Johnson Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 61. Alimera Sciences Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 62. Teva Pharmaceutical Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 63. Eyetech Pharmaceuticals Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 64. Refocus Group Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 65. VisionCare Ophthalmic Technologies Revenue Growth Rate in Eye Disorders Treatments Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Johnson & Johnson Novartis Alimera Sciences Teva Pharmaceutical Eyetech Pharmaceuticals Refocus Group VisionCare Ophthalmic Technologies